Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Genetic Tech Spn ADR
(NQ:
GENE
)
2.280
-0.010 (-0.44%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Genetic Tech Spn ADR
< Previous
1
2
Next >
Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
July 28, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
July 21, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType featured on U.S. National TV to raise Breast Cancer Awareness
May 23, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
New Publication Validates geneType for Melanoma Risk Assessment
April 28, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Quarterly Business Update – March 2023
April 27, 2023
Driving growth, Expanded Multi-Test Panel and Publications Validating Clinical Utility of geneType
From
Genetic Technologies Ltd
Via
GlobeNewswire
Publication Validates geneType Prostate Cancer Risk Test
April 19, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation
March 27, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Back-to-back Studies Validate geneType Breast Cancer Risk Test
March 13, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
New Publication Highlights geneType’s Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification
February 09, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Announces $5 Million Registered Direct Offering
February 03, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer
February 03, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
GTG to form Strategic Alliance with global testing leader QIAGEN
February 01, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth
January 30, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Presented Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk at ASCOGI Cancer Symposium
January 24, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Provides Business Update
January 11, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
GeneType published in PLOS ONE – development of polygenic risk scores for cardiovascular diseases and type 2 diabetes
December 06, 2022
From
Genetic Technologies Ltd
Via
GlobeNewswire
Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease
November 10, 2022
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention
November 09, 2022
From
Genetic Technologies Ltd
Via
GlobeNewswire
Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
October 13, 2022
Via
ACCESSWIRE
Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
September 29, 2022
From
Genetic Technologies Ltd
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.